Anatomic Stage I Breast Cancer AJCC v8 Clinical Trials in Los Angeles, California

4 studies are recruiting for anatomic stage i breast cancer ajcc v8 in Los Angeles, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial

    This phase II trial studies how well imlunestrant and abemaciclib work in treating patients with estrogen receptor positive (ER+) breast cancer who have tumor remaining in the blood following treatment (minimal residual disease). Estrogen can cause the growth of breast cancer cells. Imlunestrant lo…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
    Run by
    Jonsson Comprehensive Cancer Center

    See if you can join NCT07191717 on ClinicalTrials.gov

  2. Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors

    This phase II trial tests whether fisetin works to improve physical function in women who have received chemotherapy for stage I-III breast cancer treatment. Fisetin is a naturally occurring substance that is found in strawberries and other foods. Fisetin eliminates cells that have undergone a proc…

    Stage
    Phase 2
    Ages
    Any age
    Site
    UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
    Locations
    7 in total
    Run by
    Jonsson Comprehensive Cancer Center

    See if you can join NCT05595499 on ClinicalTrials.gov

  3. Breast Cancer Survivorship Biorepository

    This study collects blood samples as well as clinical and self-report data from stage I-III breast cancer survivors to create a biorepository for future use. The creation of this biorepository will allow for future research into links between individual, molecular, and genomic signatures and cancer…

    Stage
    Not phased
    Ages
    18 and older
    Site
    USC / Norris Comprehensive Cancer Center, Los Angeles, California
    Run by
    University of Southern California

    See if you can join NCT05786664 on ClinicalTrials.gov

  4. Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

    This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells f…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Kaiser Permanente Los Angeles Medical Center, Los Angeles, California
    Locations
    963 in total
    Run by
    SWOG Cancer Research Network

    See if you can join NCT05929768 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.